In vitro generation of human red blood cells: A research model;La génération in vitro de globules rouges humains: Un modèle de recherche

Hematologie

Volumn 13, Issue 2, 2007, Pages 82-93

  Douay, Luc ^a,b   Lapillonne, Hélène ^a,b   Garderet, Laurent ^a   Giarratana, Marie Catherine ^a   Cartron, Jean Pierre ^c,d  

^a INSERM   (France)

^b ARMAND TROUSSEAU HOSPITAL   (France)

^c hôpital Robert Debré et Institut national de la transfusion sanguine   (France)

^d INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

Erythropoiesis; Hematopoietic stem cell; Red blood cell

Indexed keywords

ASPARAGINASE; ERYTHROPOIETIN; HEMOGLOBIN; INTERLEUKIN 3; STEM CELL FACTOR;

CELL DIFFERENTIATION; CELL PROLIFERATION; EMBRYO CELL; ERYTHROCYTE; ERYTHROPOIESIS; HEMATOPOIETIC STEM CELL; HEMOGLOBIN SYNTHESIS; HEMOLYTIC ANEMIA; HUMAN; IN VITRO STUDY; LEUKEMIA; MYELODYSPLASTIC SYNDROME; PLASMODIUM FALCIPARUM; REVIEW; RNA INTERFERENCE;

EID: 34250774916     PISSN: 12647527     EISSN: None     Source Type: Journal    
DOI: 10.1684/hma.2007.0139     Document Type: Review

References (75)

1. Lichtman MA. The ultrastructure of the hemopoietic environment of the marrow : a review. Exp Hematol 1981 ; 9 : 391-410.
2. Qiu LB, Dickson H, Hajibagheri N, Crocker PR. Extruded erythroblast nuclei are bound and phagocytosed by a novel macrophage receptor. Blood 1995 ; 85 : 1630-9.
3. Pasini EM, Kirkegoard M, Mortensen P, et al. In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 2006 ; 108 : 791-801.
4. Sui X, et al. Erythropoietin-independent erythrocyte production : signals through gpl30 and c-kit dramatically promote erythropoiesis from human CD34+ cells. J Exp Med 1996 ; 183 : 837-45.
5. von Lindern M, et al. The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro. Blood 1999 ; 94 : 550-9.
6. Freyssinier JM, et al. Purification, amplification and characterization of a population of human erythroid progenitors. Br J Haematol 1999 ; 106 : 912-22.
7. Panzenbock B, Bartunek P, Mapara MY, Zenke M. Growth and differentiation of human stem cell factor/erythropoietin-dependent erythroid progenitor cells in vitro. Blood 1998 ; 92 : 3658-68.
8. Fibach E, Manor D, Oppenheim A, Rachmilewitz EA. Proliferation and maturation of human erythroid progenitors in liquid culture. Blood 1989 ; 73 : 100-3.
9. Wada H, et al. Expression of major blood group antigens on human erythroid cells in a two phase liquid culture system. Blood 1990 ; 75 : 505-11.
10. Gregory CJ, Eaves AC. Three stages of erythropoietic progenitor cell differentiation distinguished by a number of physical and biologic properties. Blood 1978 ; 51 : 527-37.
11. Metcalf D. Hematopoietic regulators : redundancy or subtlety? Blood 1993 ; 82 : 3515-23.
12. Malik P, et al. An in vitro model of human red blood cell production from hematopoietic progenitor cells. Blood 1998 ; 91 : 2664-71.
13. Miharada K, Hiroyama T, Sudo K, et al. Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells. Nat Biotechnol 2006 ; 24 : 1255-6.
14. Neildez-Nguyen TM, et al. Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo. Nat Biotechnol 2002 ; 20 : 467-72.
15. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993 ; 81 : 2844-53.
16. Lemischka IR. Microenvironmental regulation of hematopoietic stem cells. Stem Cells 1997 ; 15(Suppl 1) : 63-8.
17. Friedenstein AJ, et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 1974 ; 2 : 83-92.
18. Verfaillie CM. Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation. Blood 1993 ; 82 : 2045-53.
19. Giarratana M, Kobari L, Lapillonne H, et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotech 2005 ; 23 : 69-74.
20. Cynober T, Mohandas N, Tchernia G. Red cell abnormalities in hereditary spherocytosis : relevance to diagnosis and understanding of the variable expression of clinical severity. J Lab Clin Med 1996 ; 128 : 259-69.
21. Bessis M, Breton-Gorius J. Iron metabolism in the bone marrow as seen by electron microscopy : a critical review. Blood 1962 ; 19 : 635-63.
22. Bernard J. The erythroblastic island : past and future. Blood Cells 1991 ; 17 : 5-10.
23. Crocker PR, Gordon S. Isolation and characterization of resident stromal macrophages and hematopoietic cell clusters from mouse bone marrow. J Exp Med 1985 ; 162 : 993-1014.
24. Macario AJL, Dugan C, Perez-Lioret IL, De Macario EC. Purification of erythroblastic nests. Blood 1981 ; 57 : 922-7.
25. Hanspal M, Hanspal JS. The association of erythroblasts with macrophages promotes erythroid proliferation and maturation : a 30-kD heparin-binding protein is involved in this contact. Blood 1994 ; 84 : 3494-504.
26. Hanspal M, Smockova Y, Uong Q. Molecular identification and functional characterization of a novel protein that mediates the attachment of erythroblasts to macrophages. Blood 1998 ; 92 : 2940-50.
27. Soni S, Bala S, Gwynn B, et al. Absence of EMP leads to failure of erythroblast nuclear extrusion. J Biol Chem 2006 ; 281 : 20181-9.
28. Telen MJ. Erythrocyte adhesion receptors : blood group antigens and related molecules. Transf Med Rev 2005 ; 19 : 32-44.
29. Chasis JA. Erythroblastic islands : specialized microenvironmental niches for erythropoiesis. Curr Opin Hematol 2006 ; 13 : 137-41.
30. Sahadira Y, Yoshino T, Monobe Y. Very late activation antigen 4-vascular cell adhesion molecule 1 interaction is involved in the formation of erythroblastic islands. J Exp Med 1995 ; 181 : 411-5.
31. Lee G, Lo AJ, Short S, et al. Targeted gene deletion demonstrates that adhesion molecule ICAM-4 is critical for erythroblastic island formation. Blood 2006 ; 108 : 2064-71.
32. Loeuillet C, et al. Distinct hematopoietic support by two human stromal cell lines. Exp Hematol 2001 ; 29 : 736-45.
33. Loeuillet C, Douay L, Herve P, Chalmers DE. Preservation of the myofibroblastic phenotype of human papilloma virus 16 E6/E7 immortalized human bone marrow cells using the lineage limited alpha-smooth muscle actin promoter. Cell Growth Differ 2001 ; 12 : 233-42.
34. Leberhauer C, Boulme F, Unfried G, et al. Different steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors. Blood 2005 ; 105 : 85-94.
35. Liebhaber SA, Wang Z, Cash FE, Monks B, Russel JE. Developmental silencing of the embryonic zeta-globin gene : concerted action of the promoter and the 3′-flanking region combined with stage-specific silencing by the transcribed segment. Mol Cell Biol 1996 ; 16 : 2637-46.
36. Eliason J. Granulocyte-macrophage colony formation in serum-free culture : effects of purified colony-stimulating factors and modulation by hydrocortisone. J Cell Physiol 1986 ; 128 : 231-8.
37. Gabbianelli M, Testa U, Massa A, Pelosi E, Sposi NM, Riccioni R, Pelosi E, Luchetti L, Peschlec C. Hemoglobin switching in unicellular erythroid culture of sibling erythroid burst-forming units : kit ligand induces a dose-dependent fetal hemoglobin reactivation potentiated by sodium butyrate. Blood 2000 ; 95 : 3555-61.
38. Stamatoyannopoulos G, Papayannopoulou TH. The switching from hemoglobin F to hemoglobin A formation in man : parallels between the observations in vivo and the findings in erythroid cultures. In the red cells. In : Fifth Ann Arbor Conference (Brewer GJ eds). 1981 : 665-9.
39. Alter BP, Goldberg JD, Jackson BT, Piasecki GJ, Lipton JM, Nathan DG. Evidence for a clonal model for hemoglobin switching. In : In globin gene expression and hematopoietic differenciation (Stamatoyannopoulos G, Nienhuis eds). 1983 : 431-41.
40. Dalyot N, Fibach E, Rachmilewitz EA, Oppenheim A. Adult and neonatal patterns of human globin gene expression are recapitulated in liquid cultures. Exp Hematol 1992 ; 20 : 1141-5.
41. Stamatoyannopoulos G. Control of globin gene expression during development and erythroid differentiation. Exp Hematol 2005 ; 33 : 259-71.
42. Gabbianelli M, Pelosi E, Bassano E, Labbaye C, Petti S, Rocca E, Tritarelli E, Miller BA, Valtieri M, Testa U. Granulocyte-macrophage colony-stimulating factor reactivates fetal hemoglobin synthesis in erythroblast clones from normal adults. Blood 1989 ; 74 : 2657-67.
43. Fibach E, Manor D, Oppenheim A, Rachmilewitz EA. Proliferation and maturation of human erythroid progenitors in liquid culture. Blood 1989 ; 73 : 100-3.
44. Fibach E. Techniques for studying stimulation of fetal hemoglobin production in human erythroid cultures. Hemoglobin 1998 ; 22 : 445-8.
45. Pope SH, Fibach E, Sun J, Chin K, Rogers GP. Two-phase liquid culture system models normal human adult erythropoiesis at the molecular level. Eur J Haematol 2000 ; 64 : 292-303.
46. Rutherford T, Clegg JB, Higgs DR, Jones RW, Thompson J, Weatherall DJ. Embryonic erythroid differentiation in the human leukemic cell line K562. Proc Natl Acad Sci USA 1981 ; 78 : 348-52.
47. Stamatoyannopoulos G, Grosveld F. Hemoglobin switching. In the Molecular Basis of Blood Diseases. 3re ed. In : Part II, Red Celts (Stamatoyannopoulos G, Majerus P, Perlmutter R, Varmus H eds). Philadelphia : WB Saunders Publishing Co, 2001 : 135-82.
48. Catenacci DVT, Schiller GJ. Myelodysplastic syndromes : a comprehensive review. Blood Rev 2005 ; 6 : 301-19.
49. Cazzola M, Malcovati L. Myelodysplastic syndromes-Coping with ineffective hematopoiesis. N Engl J Med 2005 ; 352 : 536-8.
50. Verbeek W, Ganser A. Evolving treatment options of myelodysplastic syndromes. Ann Hematol 2001 ; 80 : 499-509.
51. Raza A, Gezer S, Mundle S, et al. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 1995 ; 86 : 268-76.
52. Yoshida Y. Hypothesis : apoptosis may be the mechanism responsible for the premature intramedullary cell death in the myelodysplastic syndrome. Leukemia 1993 ; 7 : 144-6.
53. Testa U. Apoptotic mechanisms in the control of erythropoiesis. Leukemia 2004 ; 18 : 1176-99.
54. Claessens YE, Bouscary D, Dupont JM, et al. In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes : evidence for Fas-dependent apoptosis. Blood 2002 ; 99 : 1594-601.
55. Claessens YE, Park S, Dubart-Kupperschmitt A, et al. Rescue of early-stage myelodysplastic syndrome-deriving erythroid precursors by the ectopic expression of a dominant-negative form of FADD. Blood 2005 ; 105 : 4035-42.
56. Chauchereau A, Harel-Bellan A. Inactivation fonctionnelle des genes par ARN interference. Hématologie 2004 ; 10 : 68-79.
57. Sledz CA, Williams BRG. RNA interference in biology and disease. Blood 2005 ; 106 : 787-94.
58. Garçon L, Lacout C, Svinartchouk F, et al. Gfi-1B plays a critical role in terminal differentiation of normal and transformed erythroid progenitor cells. Blood 2005 ; 105 : 1448-55.
59. James C, Ugo V, Le Couédic JP, Staerk J, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythemia vera. Nature 2005 ; 434 : 1144-8.
60. Garcon L, Rivat C, James C, et al. Constitutive activation of STAT5 and Bcl-xL overexpression can induce endogenous erythroid colony formation in human primary cells. Blood 2006 ; 108 : 1551-4.
61. Flygare J, Kiefer T, Miyake K, et al. Deficiency of ribosomal protein S19 in CD34+ cells generated by siRNA blocks erythroid development and mimics defects seen in Diamond-Blackfan anemia. Blood 2005 ; 105 : 4627-34.
62. null. Hématologie 1997 ; 3 : 207-20.
63. Cartron JP. RH blood group system and molecular basis of Rh-deficiency. Baillieres Clin Haematol 1999 ; 12 : 655-89.
64. Oldenborg PA, Zheleznyak A, Fang YF, Lagenaur CF, Gresham HD, Lindberg FP. Role of CD47 as a marker of self on red blood cells. Science 2000 ; 288 : 2051-4.
65. Danek A, Jung HH, Melone MAB, Rampoldi L, Broccoli V, Walker RH. Neuroacanthocytosis : new developments in a neglected group of dementing disorders. J Neurol Sci 2005 ; 229-230 : 171-86.
66. Redman CM, Marsh WL. The Kell blood group system and the McLeod phenotype. Semin Hematol 1993 ; 30 : 209-18.
67. Mons B, et al. Synchronised erythrocytic schizogony and gametocytogenesis of Plasmodium berghei in vivo and in vitro. Parasitology 1985 ; 9 : 423-30.
68. Rieckmann KH, et al. Drug sensitivity of Plasmodium falciparum. An in vitro microtechnique. Lancet 1978 ; 1 : 22-3.
69. Rossi L, Serafini S, Pierige F, Antonelli A, Cerasi A, Fraternale A, et al. Erythrocyte-based drug delivery. Expert Opin Drug Deliv 2005 ; 2 : 311-22.
70. Milan CG, Marinero ML, Castaneda AZ, Lanao JM. Drug, enzyme, and peptide delivery using erythrocytes as carriers. J Control Release 2004 ; 95 : 27-49.
71. Kravtzoff R, Colombat P, Desbois I, Linassier C, Muh JP, Philip T, Blay J, et al. Tolerance evaluation of L-asparaginase loaded in red blood cells. Eur J Pharmacol 1996 ; 51 : 221-5.
72. Teisseire B, Ropars C, Villereal MC, Nicolau C. Long-term physiological effects of enhanced O2 release by inositol hexaphosphate-loaded erythrocytes. Proc Natl Acad Sci USA 1987 ; 84 : 6894-8.
73. Keller G. Embryonic stem cell differentiation : emergence of a new era in biology and medicine. Genes Dev 2005 ; 19 : 1129-55.
74. Stamatoyannopoulos G. Control of globin gene expression during development and erythroid differentiation. Exp Hematol 2005 ; 33 : 259-71.
75. Qiu C, Hanson E, Olivier E, et al. Differentiation of human embryonic stem cells into hematopoietic cells by coculture with human fetal liver cells recapitulates the globin switch that occurs early in development. Exp Hematol 2005 ; 33 : 1450-8.